Contrast-enhanced ultrasound imaging of antiangiogenic tumor therapy
Anti-angiogenic treatment is a promising strategy for cancer therapy and is currently evaluated in clinical trials. The aim of the present study was to further investigate the effects of an anti-angiogenic therapy, inhibiting vascular endothelial growth factor (VEGF) and endothelial growth factor (E...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2015
|
| In: |
Anticancer research
Year: 2015, Volume: 35, Issue: 5, Pages: 2571-2576 |
| ISSN: | 1791-7530 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: http://ar.iiarjournals.org/content/35/5/2571
|
| Author Notes: | Laura V. Klotz, Dirk-Andre Clevert, Siiri Scheckinger, Sebastian Strieth and Martin E. Eichhorn |
| Summary: | Anti-angiogenic treatment is a promising strategy for cancer therapy and is currently evaluated in clinical trials. The aim of the present study was to further investigate the effects of an anti-angiogenic therapy, inhibiting vascular endothelial growth factor (VEGF) and endothelial growth factor (EGF) using a tyrosine kinase inhibitor for blocking tumor angiogenesis and tumor progression in vivo. |
|---|---|
| Item Description: | Gesehen am 08.07.2020 |
| Physical Description: | Online Resource |
| ISSN: | 1791-7530 |